샘플 요청 목록

 카트 문의
시장보고서
상품코드
1794562

세계의 안근마비 시장

Ophthalmoplegia
발행일: | 리서치사: Market Glass, Inc. (Formerly Global Industry Analysts, Inc.) | 페이지 정보: 영문 276 Pages | 배송안내 : 1-2일 (영업일 기준)

    
    
    



※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

안근마비 세계 시장은 2030년까지 18억 달러에 달할 전망

2024년에 13억 달러로 추정되는 안근마비 세계 시장은 2024년부터 2030년까지 CAGR 4.8%로 성장하여 2030년에는 18억 달러에 달할 것으로 예측됩니다. 안근마비 보고서에서 분석한 부문 중 하나인 의약품은 CAGR 5.7%를 기록하며 분석 기간 종료까지 11억 달러에 달할 것으로 예측됩니다. 안근마비 의료기기 부문의 성장률은 분석 기간 동안 CAGR 3.1%로 추정됩니다.

미국 시장은 3억 6,130만 달러로 추정, 중국은 CAGR 8.8%로 성장 예측

미국의 안근마비 시장은 2024년에 3억 6,130만 달러로 추정됩니다. 세계 2위 경제 대국인 중국은 2024년부터 2030년 분석 기간 동안 CAGR 8.8%로 성장하여 2030년에는 3억 7,010만 달러의 시장 규모에 달할 것으로 예측됩니다. 기타 주목할 만한 지역별 시장으로는 일본과 캐나다가 있고, 분석 기간 동안 CAGR은 각각 1.9%와 3.8%로 예측됩니다. 유럽에서는 독일이 CAGR 2.8%로 성장할 것으로 예측됩니다.

세계의 안근마비 치료 상황 - 주요 동향과 촉진요인 정리

안근마비의 진단과 관리에 대한 임상적 관심의 원동력은 무엇인가?

안근마비란 안근의 마비 또는 약화를 말하며, 정상적인 안구 운동을 제한하고 하나 또는 여러 개의 안구 근육에 영향을 미칠 수 있습니다. 이 질환은 뇌신경마비, 뇌졸중, 외상, 다발성 경화증, 감염, 또는 만성 진행성 외반증과 같은 희귀한 미토콘드리아 질환 등 다양한 근본적인 원인에 의해 발생할 수 있습니다. 환자는 복시, 안검하수, 시선조절장애, 균형장애 및 협응운동장애를 경험할 수 있습니다.

신경증상에 대한 인식이 높아지고, 신경안과 진단에 대한 접근성이 개선되면서 조기 발견과 개입이 가능해졌습니다. MRI, CT 스캔과 같은 영상 진단 기술은 안구 운동 평가 및 혈액 검사와 결합하여 원인 질환의 확인 및 선천성, 후천성, 진행성 질환의 감별에 사용되고 있습니다. 뇌졸중, 당뇨병 관련 신경병증, 자가면역질환의 증가로 인해 이차성 안근마비를 보이는 환자 수가 증가하고 있으며, 이에 대한 관리가 임상적 초점이 되고 있습니다.

현재의 치료법이 근본적인 원인과 질병의 진행과 어떻게 일치하는가?

안근마비의 치료는 근본적인 원인과 근육 병변의 중증도에 따라 달라지기 때문에 만능 치료법은 존재하지 않습니다. 감염, 염증, 자가면역 반응과 관련된 경우 증상을 억제하기 위해 코르티코스테로이드나 면역억제제를 처방합니다. 당뇨병이나 혈관질환으로 인한 뇌신경마비의 경우, 프리즘 안경이나 안대를 사용하여 복시를 관리하면서 원질환을 치료하는 경우가 많습니다.

복시가 지속되거나 안구 정렬에 큰 영향을 미치는 경우에는 사시교정술과 같은 수술적 방법을 고려하게 됩니다. 미토콘드리아성 또는 진행성 신경퇴행으로 인한 환자는 물리치료, 약시 재활치료 등의 지지요법을 받을 수 있습니다. 경우에 따라서는 기존의 장애를 회복시키는 것이 아니라 질병의 진행을 막는 것을 목적으로 하는 치료가 이루어지기도 합니다. 유전자 검사와 신경학적 평가의 접근성이 높아짐에 따라 정확한 진단이 보다 맞춤화된 다학제적 치료 전략을 뒷받침할 수 있게 되었습니다.

안근마비의 광범위한 치료 환경에서 어떤 트렌드가 생겨나고 있는가?

안근마비 치료에서 다직종 협진이 차지하는 역할이 커지고 있습니다. 신경과, 안과, 재활의학과 전문의는 특히 안구 운동 장애에 전신 증상이나 인지 증상이 동반되는 경우, 복잡한 병태를 관리하기 위해 협력하는 경우가 많습니다. 환자 모니터링은 특히 만성 및 진행성 질환의 경우, 삶의 질과 기능적 독립성 유지에 중점을 둔 장기적인 치료의 틀로 전환되고 있습니다.

웨어러블 아이트래킹 기술과 시각 훈련 애플리케이션의 통합은 증상 모니터링과 재활에 새로운 길을 제공하고 있습니다. 신경안과학의 발전은 뇌와 안근의 상호 작용에 대한 이해를 높이고 진단 프로토콜을 개선하는 데 도움이 될 것입니다. 또한, 희귀 미토콘드리아 및 신경근육 질환에 대한 전 세계적인 인식 개선 노력은 특히 젊은 연령층에서 임상 경로를 조기에 파악하는 데 도움이 되고 있습니다.

안근마비 관리 및 치료 시장의 성장을 촉진하는 요인은 무엇인가?

안근마비 케어 시장의 성장은 몇 가지 요인에 의해 이루어집니다. 신경질환, 당뇨병 관련 신경 손상, 자가면역질환의 유병률 증가로 인해 평가와 중재가 필요한 환자층이 확대되고 있습니다. 영상 진단과 진단 능력의 발전으로 근육과 신경의 병변을 더 빨리, 더 정확하게 파악할 수 있게 되었습니다. 신경근육질환 및 미토콘드리아 질환에 대한 표적 치료제의 개발로 희귀질환 및 진행성 질환에 대한 치료 옵션이 확대되고 있습니다. 전문 신경안과 서비스의 확대로 인해, 다학제적 치료에 대한 접근성이 향상되고 있습니다. 전신 질환과 관련된 눈 증상에 대한 인식이 높아짐에 따라 적시에 의뢰가 이루어지고 진단 지연이 줄어들고 있습니다. 이러한 요인들을 종합하면, 전 세계 의료 시스템 전체에서 안근마비를 보다 체계적이고 효과적으로 관리할 수 있는 경로가 마련될 수 있습니다.

부문

제품 유형(안근마비 의약품, 안근마비 의료기기), 최종 용도(병원, 진료소, 외래 진료소)

조사 대상 기업 사례

  • Accutome(Keeler)
  • AcuSurgical
  • Allergan(AbbVie)
  • Appasamy Associates
  • Barraquer Institute(neuromodulators)
  • Daewoong Pharmaceutical(Nabota/Jeuveau)
  • Duckworth & Kent
  • Eyenovia Inc.(topical/neuro)
  • Evolus(Jeuveau)
  • Ipsen(Dysport)
  • Keeler(Accutome)
  • Medytox(Neuronox)
  • Optonol/Belkin Vision
  • Preceyes BV
  • Rayner
  • Schwind eye-tech-solutions
  • Storz(Bausch + Lomb)
  • Teva Pharmaceutical(Xeomin)
  • VisuMax/Carl Zeiss(MIGS devices)
  • Ziemer Ophthalmic Systems

AI 통합

Global Industry Analysts는 검증된 전문가 컨텐츠와 AI 툴을 통해 시장 정보와 경쟁 정보를 혁신하고 있습니다.

Global Industry Analysts는 LLM 및 업계 고유의 SLM을 조회하는 일반적인 규범을 따르는 대신 비디오 기록, 블로그, 검색 엔진 조사, 방대한 양의 기업, 제품/서비스, 시장 데이터 등 세계 도메인 전문가가 선별한 컨텐츠 리포지토리를 구축했습니다.

관세 영향 계수

Global Industry Analysts는 본사 소재지, 제조거점, 수출입(완제품 및 OEM)을 기준으로 기업의 경쟁력 변화를 예측하고 있습니다. 이러한 복잡하고 다면적인 시장 역학은 매출원가(COGS) 증가, 수익성 하락, 공급망 재편 등 미시적, 거시적 시장 역학 중에서도 특히 경쟁사들에게 영향을 미칠 것으로 예상됩니다.

목차

제1장 조사 방법

제2장 주요 요약

  • 시장 개요
  • 주요 기업
  • 시장 동향과 촉진요인
  • 세계 시장 전망

제3장 시장 분석

  • 미국
  • 캐나다
  • 일본
  • 중국
  • 유럽
  • 프랑스
  • 독일
  • 이탈리아
  • 영국
  • 스페인
  • 러시아
  • 기타 유럽
  • 아시아태평양
  • 호주
  • 인도
  • 한국
  • 기타 아시아태평양
  • 라틴아메리카
  • 아르헨티나
  • 브라질
  • 멕시코
  • 기타 라틴아메리카
  • 중동
  • 이란
  • 이스라엘
  • 사우디아라비아
  • 아랍에미리트
  • 기타 중동
  • 아프리카

제4장 경쟁

KSM 25.08.28

Global Ophthalmoplegia Market to Reach US$1.8 Billion by 2030

The global market for Ophthalmoplegia estimated at US$1.3 Billion in the year 2024, is expected to reach US$1.8 Billion by 2030, growing at a CAGR of 4.8% over the analysis period 2024-2030. Ophthalmoplegia Pharmaceuticals, one of the segments analyzed in the report, is expected to record a 5.7% CAGR and reach US$1.1 Billion by the end of the analysis period. Growth in the Ophthalmoplegia Medical Devices segment is estimated at 3.1% CAGR over the analysis period.

The U.S. Market is Estimated at US$361.3 Million While China is Forecast to Grow at 8.8% CAGR

The Ophthalmoplegia market in the U.S. is estimated at US$361.3 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$370.1 Million by the year 2030 trailing a CAGR of 8.8% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 1.9% and 3.8% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 2.8% CAGR.

Global Ophthalmoplegia Treatment Landscape - Key Trends & Drivers Summarized

What Is Driving Clinical Attention Toward Ophthalmoplegia Diagnosis and Management?

Ophthalmoplegia refers to the paralysis or weakness of the eye muscles, which restricts normal eye movement and may affect one or more of the extraocular muscles. This condition can result from various underlying causes including cranial nerve palsies, stroke, trauma, multiple sclerosis, infections, or rare mitochondrial diseases such as chronic progressive external ophthalmoplegia. Patients may experience double vision, drooping eyelids, impaired gaze control, and difficulties with balance or coordination.

Growing awareness of neurological symptoms and improved access to neuro-ophthalmology diagnostics are enabling earlier recognition and intervention. Imaging techniques such as MRI and CT scans, combined with ocular motility assessments and blood tests, are being used to identify causative conditions and differentiate between congenital, acquired, or progressive forms of the disorder. Rising incidence of stroke, diabetes-related neuropathy, and autoimmune disorders is increasing the number of patients presenting with secondary ophthalmoplegia, prompting greater clinical focus on its management.

How Are Current Therapies Aligned with Underlying Causes and Disease Progression?

There is no one-size-fits-all approach to treating ophthalmoplegia, as therapeutic strategies depend heavily on the underlying cause and severity of muscle involvement. In cases where the condition is linked to infection, inflammation, or autoimmune reactions, corticosteroids or immunosuppressants are typically prescribed to control symptoms. For cases involving cranial nerve palsy from diabetes or vascular events, management often includes addressing the primary disease while using prism glasses or eye patches to manage double vision.

Surgical options such as strabismus correction are considered in cases where diplopia persists or ocular alignment is significantly affected. Patients with mitochondrial or progressive neurodegenerative origins may receive supportive care, including physical therapy and low vision rehabilitation. In some instances, treatments are aimed at halting disease progression rather than reversing existing damage. As genetic testing and neurological evaluation become more accessible, accurate diagnosis is supporting more tailored and multidisciplinary treatment strategies.

What Trends Are Emerging in the Broader Care Environment for Ophthalmoplegia?

Multidisciplinary collaboration is playing a growing role in ophthalmoplegia care. Neurologists, ophthalmologists, and rehabilitation specialists often work together to manage complex presentations, especially when ocular motor deficits are accompanied by systemic or cognitive symptoms. Patient monitoring is shifting toward long-term care frameworks, particularly in chronic or progressive forms, with a focus on maintaining quality of life and functional independence.

The integration of wearable eye-tracking technologies and visual training applications is providing new avenues for symptom monitoring and rehabilitation. Advances in neuro-ophthalmology are supporting better understanding of brain-eye muscle interactions, leading to improved diagnostic protocols. Additionally, global awareness efforts around rare mitochondrial and neuromuscular disorders are helping identify ophthalmoplegia earlier in clinical pathways, especially among younger populations.

What Factors Are Driving Growth in the Ophthalmoplegia Care and Therapeutics Market?

Growth in the ophthalmoplegia care market is driven by several factors. Increasing prevalence of neurological conditions, diabetes-related nerve damage, and autoimmune disorders is expanding the patient population requiring evaluation and intervention. Advancements in imaging and diagnostic capabilities are enabling earlier and more accurate identification of muscle and nerve involvement. Development of targeted therapies for neuromuscular and mitochondrial diseases is broadening treatment options in rare and progressive cases. Expansion of specialized neuro-ophthalmology services is improving multidisciplinary access to care. Rising awareness of ocular symptoms linked to systemic disease is encouraging timely referrals and reducing diagnostic delays. Collectively, these factors are supporting more structured and effective management pathways for ophthalmoplegia across global healthcare systems.

SCOPE OF STUDY:

The report analyzes the Ophthalmoplegia market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Product Type (Ophthalmoplegia Pharmaceuticals, Ophthalmoplegia Medical Devices); End-Use (Hospitals End-Use, Clinics End-Use, Ambulatory Clinics End-Use)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 42 Featured) -

  • Accutome (Keeler)
  • AcuSurgical
  • Allergan (AbbVie)
  • Appasamy Associates
  • Barraquer Institute (neuromodulators)
  • Daewoong Pharmaceutical (Nabota/Jeuveau)
  • Duckworth & Kent
  • Eyenovia Inc. (topical/neuro)
  • Evolus (Jeuveau)
  • Ipsen (Dysport)
  • Keeler (Accutome)
  • Medytox (Neuronox)
  • Optonol / Belkin Vision
  • Preceyes BV
  • Rayner
  • Schwind eye-tech-solutions
  • Storz (Bausch + Lomb)
  • Teva Pharmaceutical (Xeomin)
  • VisuMax/Carl Zeiss (MIGS devices)
  • Ziemer Ophthalmic Systems

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Tariff Impact on Global Supply Chain Patterns
    • Ophthalmoplegia - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Incidence of Neuro-Ophthalmic Disorders and Stroke-Related Complications Drives Demand for Ophthalmoplegia Diagnosis and Treatment
    • Increased Prevalence of Diabetes and Hypertension Expands Addressable Market for Secondary Ophthalmoplegia Management
    • Advancements in Neuroimaging and MRI Technologies Strengthen Early Detection and Differential Diagnosis Capabilities
    • Growth in Awareness and Screening for Rare Muscular and Nerve Disorders Spurs Identification of Congenital Ophthalmoplegia Cases
    • Development of Targeted Therapies and Supportive Treatments Enhances Clinical Outcomes for Cranial Nerve Palsy
    • Integration of Multidisciplinary Care Approaches, Including Neurology and Ophthalmology, Improves Patient Management Strategies
    • Adoption of Botulinum Toxin Therapy and Eye Muscle Surgery Supports Functional Rehabilitation in Select Cases
    • Increased Research on Mitochondrial Disorders and Genetic Mutations Fuels Innovation in Personalized Treatment Options
    • Technological Advancements in Assistive Vision Devices Promote Quality of Life for Patients with Partial or Chronic Paralysis
    • Rising Use of Steroids and Immunomodulators in Autoimmune-Linked Ophthalmoplegia Expands Treatment Applications
    • Growth in Pediatric Neurology Services Supports Early Intervention in Developmental Ocular Motor Disorders
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Ophthalmoplegia Market Analysis of Annual Sales in US$ Thousand for Years 2014 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Ophthalmoplegia by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Ophthalmoplegia by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 4: World 16-Year Perspective for Ophthalmoplegia by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Ophthalmoplegia Pharmaceuticals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Ophthalmoplegia Pharmaceuticals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 7: World 16-Year Perspective for Ophthalmoplegia Pharmaceuticals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Ophthalmoplegia Medical Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Ophthalmoplegia Medical Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 10: World 16-Year Perspective for Ophthalmoplegia Medical Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Hospitals End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Hospitals End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 13: World 16-Year Perspective for Hospitals End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Clinics End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Clinics End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 16: World 16-Year Perspective for Clinics End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Ambulatory Clinics End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Ambulatory Clinics End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 19: World 16-Year Perspective for Ambulatory Clinics End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Ophthalmoplegia Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 20: USA Recent Past, Current & Future Analysis for Ophthalmoplegia by Product Type - Ophthalmoplegia Pharmaceuticals and Ophthalmoplegia Medical Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 21: USA Historic Review for Ophthalmoplegia by Product Type - Ophthalmoplegia Pharmaceuticals and Ophthalmoplegia Medical Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 22: USA 16-Year Perspective for Ophthalmoplegia by Product Type - Percentage Breakdown of Value Sales for Ophthalmoplegia Pharmaceuticals and Ophthalmoplegia Medical Devices for the Years 2014, 2025 & 2030
    • TABLE 23: USA Recent Past, Current & Future Analysis for Ophthalmoplegia by End-Use - Hospitals End-Use, Clinics End-Use and Ambulatory Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 24: USA Historic Review for Ophthalmoplegia by End-Use - Hospitals End-Use, Clinics End-Use and Ambulatory Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 25: USA 16-Year Perspective for Ophthalmoplegia by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Clinics End-Use and Ambulatory Clinics End-Use for the Years 2014, 2025 & 2030
  • CANADA
    • TABLE 26: Canada Recent Past, Current & Future Analysis for Ophthalmoplegia by Product Type - Ophthalmoplegia Pharmaceuticals and Ophthalmoplegia Medical Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 27: Canada Historic Review for Ophthalmoplegia by Product Type - Ophthalmoplegia Pharmaceuticals and Ophthalmoplegia Medical Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 28: Canada 16-Year Perspective for Ophthalmoplegia by Product Type - Percentage Breakdown of Value Sales for Ophthalmoplegia Pharmaceuticals and Ophthalmoplegia Medical Devices for the Years 2014, 2025 & 2030
    • TABLE 29: Canada Recent Past, Current & Future Analysis for Ophthalmoplegia by End-Use - Hospitals End-Use, Clinics End-Use and Ambulatory Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 30: Canada Historic Review for Ophthalmoplegia by End-Use - Hospitals End-Use, Clinics End-Use and Ambulatory Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 31: Canada 16-Year Perspective for Ophthalmoplegia by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Clinics End-Use and Ambulatory Clinics End-Use for the Years 2014, 2025 & 2030
  • JAPAN
    • Ophthalmoplegia Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 32: Japan Recent Past, Current & Future Analysis for Ophthalmoplegia by Product Type - Ophthalmoplegia Pharmaceuticals and Ophthalmoplegia Medical Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 33: Japan Historic Review for Ophthalmoplegia by Product Type - Ophthalmoplegia Pharmaceuticals and Ophthalmoplegia Medical Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 34: Japan 16-Year Perspective for Ophthalmoplegia by Product Type - Percentage Breakdown of Value Sales for Ophthalmoplegia Pharmaceuticals and Ophthalmoplegia Medical Devices for the Years 2014, 2025 & 2030
    • TABLE 35: Japan Recent Past, Current & Future Analysis for Ophthalmoplegia by End-Use - Hospitals End-Use, Clinics End-Use and Ambulatory Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 36: Japan Historic Review for Ophthalmoplegia by End-Use - Hospitals End-Use, Clinics End-Use and Ambulatory Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 37: Japan 16-Year Perspective for Ophthalmoplegia by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Clinics End-Use and Ambulatory Clinics End-Use for the Years 2014, 2025 & 2030
  • CHINA
    • Ophthalmoplegia Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 38: China Recent Past, Current & Future Analysis for Ophthalmoplegia by Product Type - Ophthalmoplegia Pharmaceuticals and Ophthalmoplegia Medical Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 39: China Historic Review for Ophthalmoplegia by Product Type - Ophthalmoplegia Pharmaceuticals and Ophthalmoplegia Medical Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 40: China 16-Year Perspective for Ophthalmoplegia by Product Type - Percentage Breakdown of Value Sales for Ophthalmoplegia Pharmaceuticals and Ophthalmoplegia Medical Devices for the Years 2014, 2025 & 2030
    • TABLE 41: China Recent Past, Current & Future Analysis for Ophthalmoplegia by End-Use - Hospitals End-Use, Clinics End-Use and Ambulatory Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 42: China Historic Review for Ophthalmoplegia by End-Use - Hospitals End-Use, Clinics End-Use and Ambulatory Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 43: China 16-Year Perspective for Ophthalmoplegia by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Clinics End-Use and Ambulatory Clinics End-Use for the Years 2014, 2025 & 2030
  • EUROPE
    • Ophthalmoplegia Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 44: Europe Recent Past, Current & Future Analysis for Ophthalmoplegia by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 45: Europe Historic Review for Ophthalmoplegia by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 46: Europe 16-Year Perspective for Ophthalmoplegia by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2025 & 2030
    • TABLE 47: Europe Recent Past, Current & Future Analysis for Ophthalmoplegia by Product Type - Ophthalmoplegia Pharmaceuticals and Ophthalmoplegia Medical Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 48: Europe Historic Review for Ophthalmoplegia by Product Type - Ophthalmoplegia Pharmaceuticals and Ophthalmoplegia Medical Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 49: Europe 16-Year Perspective for Ophthalmoplegia by Product Type - Percentage Breakdown of Value Sales for Ophthalmoplegia Pharmaceuticals and Ophthalmoplegia Medical Devices for the Years 2014, 2025 & 2030
    • TABLE 50: Europe Recent Past, Current & Future Analysis for Ophthalmoplegia by End-Use - Hospitals End-Use, Clinics End-Use and Ambulatory Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Europe Historic Review for Ophthalmoplegia by End-Use - Hospitals End-Use, Clinics End-Use and Ambulatory Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 52: Europe 16-Year Perspective for Ophthalmoplegia by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Clinics End-Use and Ambulatory Clinics End-Use for the Years 2014, 2025 & 2030
  • FRANCE
    • Ophthalmoplegia Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 53: France Recent Past, Current & Future Analysis for Ophthalmoplegia by Product Type - Ophthalmoplegia Pharmaceuticals and Ophthalmoplegia Medical Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 54: France Historic Review for Ophthalmoplegia by Product Type - Ophthalmoplegia Pharmaceuticals and Ophthalmoplegia Medical Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 55: France 16-Year Perspective for Ophthalmoplegia by Product Type - Percentage Breakdown of Value Sales for Ophthalmoplegia Pharmaceuticals and Ophthalmoplegia Medical Devices for the Years 2014, 2025 & 2030
    • TABLE 56: France Recent Past, Current & Future Analysis for Ophthalmoplegia by End-Use - Hospitals End-Use, Clinics End-Use and Ambulatory Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 57: France Historic Review for Ophthalmoplegia by End-Use - Hospitals End-Use, Clinics End-Use and Ambulatory Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 58: France 16-Year Perspective for Ophthalmoplegia by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Clinics End-Use and Ambulatory Clinics End-Use for the Years 2014, 2025 & 2030
  • GERMANY
    • Ophthalmoplegia Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 59: Germany Recent Past, Current & Future Analysis for Ophthalmoplegia by Product Type - Ophthalmoplegia Pharmaceuticals and Ophthalmoplegia Medical Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 60: Germany Historic Review for Ophthalmoplegia by Product Type - Ophthalmoplegia Pharmaceuticals and Ophthalmoplegia Medical Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 61: Germany 16-Year Perspective for Ophthalmoplegia by Product Type - Percentage Breakdown of Value Sales for Ophthalmoplegia Pharmaceuticals and Ophthalmoplegia Medical Devices for the Years 2014, 2025 & 2030
    • TABLE 62: Germany Recent Past, Current & Future Analysis for Ophthalmoplegia by End-Use - Hospitals End-Use, Clinics End-Use and Ambulatory Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 63: Germany Historic Review for Ophthalmoplegia by End-Use - Hospitals End-Use, Clinics End-Use and Ambulatory Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 64: Germany 16-Year Perspective for Ophthalmoplegia by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Clinics End-Use and Ambulatory Clinics End-Use for the Years 2014, 2025 & 2030
  • ITALY
    • TABLE 65: Italy Recent Past, Current & Future Analysis for Ophthalmoplegia by Product Type - Ophthalmoplegia Pharmaceuticals and Ophthalmoplegia Medical Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 66: Italy Historic Review for Ophthalmoplegia by Product Type - Ophthalmoplegia Pharmaceuticals and Ophthalmoplegia Medical Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 67: Italy 16-Year Perspective for Ophthalmoplegia by Product Type - Percentage Breakdown of Value Sales for Ophthalmoplegia Pharmaceuticals and Ophthalmoplegia Medical Devices for the Years 2014, 2025 & 2030
    • TABLE 68: Italy Recent Past, Current & Future Analysis for Ophthalmoplegia by End-Use - Hospitals End-Use, Clinics End-Use and Ambulatory Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Italy Historic Review for Ophthalmoplegia by End-Use - Hospitals End-Use, Clinics End-Use and Ambulatory Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 70: Italy 16-Year Perspective for Ophthalmoplegia by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Clinics End-Use and Ambulatory Clinics End-Use for the Years 2014, 2025 & 2030
  • UNITED KINGDOM
    • Ophthalmoplegia Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 71: UK Recent Past, Current & Future Analysis for Ophthalmoplegia by Product Type - Ophthalmoplegia Pharmaceuticals and Ophthalmoplegia Medical Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 72: UK Historic Review for Ophthalmoplegia by Product Type - Ophthalmoplegia Pharmaceuticals and Ophthalmoplegia Medical Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 73: UK 16-Year Perspective for Ophthalmoplegia by Product Type - Percentage Breakdown of Value Sales for Ophthalmoplegia Pharmaceuticals and Ophthalmoplegia Medical Devices for the Years 2014, 2025 & 2030
    • TABLE 74: UK Recent Past, Current & Future Analysis for Ophthalmoplegia by End-Use - Hospitals End-Use, Clinics End-Use and Ambulatory Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 75: UK Historic Review for Ophthalmoplegia by End-Use - Hospitals End-Use, Clinics End-Use and Ambulatory Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 76: UK 16-Year Perspective for Ophthalmoplegia by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Clinics End-Use and Ambulatory Clinics End-Use for the Years 2014, 2025 & 2030
  • SPAIN
    • TABLE 77: Spain Recent Past, Current & Future Analysis for Ophthalmoplegia by Product Type - Ophthalmoplegia Pharmaceuticals and Ophthalmoplegia Medical Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 78: Spain Historic Review for Ophthalmoplegia by Product Type - Ophthalmoplegia Pharmaceuticals and Ophthalmoplegia Medical Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 79: Spain 16-Year Perspective for Ophthalmoplegia by Product Type - Percentage Breakdown of Value Sales for Ophthalmoplegia Pharmaceuticals and Ophthalmoplegia Medical Devices for the Years 2014, 2025 & 2030
    • TABLE 80: Spain Recent Past, Current & Future Analysis for Ophthalmoplegia by End-Use - Hospitals End-Use, Clinics End-Use and Ambulatory Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 81: Spain Historic Review for Ophthalmoplegia by End-Use - Hospitals End-Use, Clinics End-Use and Ambulatory Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 82: Spain 16-Year Perspective for Ophthalmoplegia by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Clinics End-Use and Ambulatory Clinics End-Use for the Years 2014, 2025 & 2030
  • RUSSIA
    • TABLE 83: Russia Recent Past, Current & Future Analysis for Ophthalmoplegia by Product Type - Ophthalmoplegia Pharmaceuticals and Ophthalmoplegia Medical Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 84: Russia Historic Review for Ophthalmoplegia by Product Type - Ophthalmoplegia Pharmaceuticals and Ophthalmoplegia Medical Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 85: Russia 16-Year Perspective for Ophthalmoplegia by Product Type - Percentage Breakdown of Value Sales for Ophthalmoplegia Pharmaceuticals and Ophthalmoplegia Medical Devices for the Years 2014, 2025 & 2030
    • TABLE 86: Russia Recent Past, Current & Future Analysis for Ophthalmoplegia by End-Use - Hospitals End-Use, Clinics End-Use and Ambulatory Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Russia Historic Review for Ophthalmoplegia by End-Use - Hospitals End-Use, Clinics End-Use and Ambulatory Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 88: Russia 16-Year Perspective for Ophthalmoplegia by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Clinics End-Use and Ambulatory Clinics End-Use for the Years 2014, 2025 & 2030
  • REST OF EUROPE
    • TABLE 89: Rest of Europe Recent Past, Current & Future Analysis for Ophthalmoplegia by Product Type - Ophthalmoplegia Pharmaceuticals and Ophthalmoplegia Medical Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 90: Rest of Europe Historic Review for Ophthalmoplegia by Product Type - Ophthalmoplegia Pharmaceuticals and Ophthalmoplegia Medical Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 91: Rest of Europe 16-Year Perspective for Ophthalmoplegia by Product Type - Percentage Breakdown of Value Sales for Ophthalmoplegia Pharmaceuticals and Ophthalmoplegia Medical Devices for the Years 2014, 2025 & 2030
    • TABLE 92: Rest of Europe Recent Past, Current & Future Analysis for Ophthalmoplegia by End-Use - Hospitals End-Use, Clinics End-Use and Ambulatory Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Rest of Europe Historic Review for Ophthalmoplegia by End-Use - Hospitals End-Use, Clinics End-Use and Ambulatory Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 94: Rest of Europe 16-Year Perspective for Ophthalmoplegia by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Clinics End-Use and Ambulatory Clinics End-Use for the Years 2014, 2025 & 2030
  • ASIA-PACIFIC
    • Ophthalmoplegia Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 95: Asia-Pacific Recent Past, Current & Future Analysis for Ophthalmoplegia by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 96: Asia-Pacific Historic Review for Ophthalmoplegia by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 97: Asia-Pacific 16-Year Perspective for Ophthalmoplegia by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2025 & 2030
    • TABLE 98: Asia-Pacific Recent Past, Current & Future Analysis for Ophthalmoplegia by Product Type - Ophthalmoplegia Pharmaceuticals and Ophthalmoplegia Medical Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Asia-Pacific Historic Review for Ophthalmoplegia by Product Type - Ophthalmoplegia Pharmaceuticals and Ophthalmoplegia Medical Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 100: Asia-Pacific 16-Year Perspective for Ophthalmoplegia by Product Type - Percentage Breakdown of Value Sales for Ophthalmoplegia Pharmaceuticals and Ophthalmoplegia Medical Devices for the Years 2014, 2025 & 2030
    • TABLE 101: Asia-Pacific Recent Past, Current & Future Analysis for Ophthalmoplegia by End-Use - Hospitals End-Use, Clinics End-Use and Ambulatory Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 102: Asia-Pacific Historic Review for Ophthalmoplegia by End-Use - Hospitals End-Use, Clinics End-Use and Ambulatory Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 103: Asia-Pacific 16-Year Perspective for Ophthalmoplegia by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Clinics End-Use and Ambulatory Clinics End-Use for the Years 2014, 2025 & 2030
  • AUSTRALIA
    • Ophthalmoplegia Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 104: Australia Recent Past, Current & Future Analysis for Ophthalmoplegia by Product Type - Ophthalmoplegia Pharmaceuticals and Ophthalmoplegia Medical Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 105: Australia Historic Review for Ophthalmoplegia by Product Type - Ophthalmoplegia Pharmaceuticals and Ophthalmoplegia Medical Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 106: Australia 16-Year Perspective for Ophthalmoplegia by Product Type - Percentage Breakdown of Value Sales for Ophthalmoplegia Pharmaceuticals and Ophthalmoplegia Medical Devices for the Years 2014, 2025 & 2030
    • TABLE 107: Australia Recent Past, Current & Future Analysis for Ophthalmoplegia by End-Use - Hospitals End-Use, Clinics End-Use and Ambulatory Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 108: Australia Historic Review for Ophthalmoplegia by End-Use - Hospitals End-Use, Clinics End-Use and Ambulatory Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 109: Australia 16-Year Perspective for Ophthalmoplegia by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Clinics End-Use and Ambulatory Clinics End-Use for the Years 2014, 2025 & 2030
  • INDIA
    • Ophthalmoplegia Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 110: India Recent Past, Current & Future Analysis for Ophthalmoplegia by Product Type - Ophthalmoplegia Pharmaceuticals and Ophthalmoplegia Medical Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 111: India Historic Review for Ophthalmoplegia by Product Type - Ophthalmoplegia Pharmaceuticals and Ophthalmoplegia Medical Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 112: India 16-Year Perspective for Ophthalmoplegia by Product Type - Percentage Breakdown of Value Sales for Ophthalmoplegia Pharmaceuticals and Ophthalmoplegia Medical Devices for the Years 2014, 2025 & 2030
    • TABLE 113: India Recent Past, Current & Future Analysis for Ophthalmoplegia by End-Use - Hospitals End-Use, Clinics End-Use and Ambulatory Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 114: India Historic Review for Ophthalmoplegia by End-Use - Hospitals End-Use, Clinics End-Use and Ambulatory Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 115: India 16-Year Perspective for Ophthalmoplegia by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Clinics End-Use and Ambulatory Clinics End-Use for the Years 2014, 2025 & 2030
  • SOUTH KOREA
    • TABLE 116: South Korea Recent Past, Current & Future Analysis for Ophthalmoplegia by Product Type - Ophthalmoplegia Pharmaceuticals and Ophthalmoplegia Medical Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 117: South Korea Historic Review for Ophthalmoplegia by Product Type - Ophthalmoplegia Pharmaceuticals and Ophthalmoplegia Medical Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 118: South Korea 16-Year Perspective for Ophthalmoplegia by Product Type - Percentage Breakdown of Value Sales for Ophthalmoplegia Pharmaceuticals and Ophthalmoplegia Medical Devices for the Years 2014, 2025 & 2030
    • TABLE 119: South Korea Recent Past, Current & Future Analysis for Ophthalmoplegia by End-Use - Hospitals End-Use, Clinics End-Use and Ambulatory Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 120: South Korea Historic Review for Ophthalmoplegia by End-Use - Hospitals End-Use, Clinics End-Use and Ambulatory Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 121: South Korea 16-Year Perspective for Ophthalmoplegia by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Clinics End-Use and Ambulatory Clinics End-Use for the Years 2014, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 122: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Ophthalmoplegia by Product Type - Ophthalmoplegia Pharmaceuticals and Ophthalmoplegia Medical Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 123: Rest of Asia-Pacific Historic Review for Ophthalmoplegia by Product Type - Ophthalmoplegia Pharmaceuticals and Ophthalmoplegia Medical Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 124: Rest of Asia-Pacific 16-Year Perspective for Ophthalmoplegia by Product Type - Percentage Breakdown of Value Sales for Ophthalmoplegia Pharmaceuticals and Ophthalmoplegia Medical Devices for the Years 2014, 2025 & 2030
    • TABLE 125: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Ophthalmoplegia by End-Use - Hospitals End-Use, Clinics End-Use and Ambulatory Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 126: Rest of Asia-Pacific Historic Review for Ophthalmoplegia by End-Use - Hospitals End-Use, Clinics End-Use and Ambulatory Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 127: Rest of Asia-Pacific 16-Year Perspective for Ophthalmoplegia by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Clinics End-Use and Ambulatory Clinics End-Use for the Years 2014, 2025 & 2030
  • LATIN AMERICA
    • Ophthalmoplegia Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 128: Latin America Recent Past, Current & Future Analysis for Ophthalmoplegia by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 129: Latin America Historic Review for Ophthalmoplegia by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 130: Latin America 16-Year Perspective for Ophthalmoplegia by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2025 & 2030
    • TABLE 131: Latin America Recent Past, Current & Future Analysis for Ophthalmoplegia by Product Type - Ophthalmoplegia Pharmaceuticals and Ophthalmoplegia Medical Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 132: Latin America Historic Review for Ophthalmoplegia by Product Type - Ophthalmoplegia Pharmaceuticals and Ophthalmoplegia Medical Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 133: Latin America 16-Year Perspective for Ophthalmoplegia by Product Type - Percentage Breakdown of Value Sales for Ophthalmoplegia Pharmaceuticals and Ophthalmoplegia Medical Devices for the Years 2014, 2025 & 2030
    • TABLE 134: Latin America Recent Past, Current & Future Analysis for Ophthalmoplegia by End-Use - Hospitals End-Use, Clinics End-Use and Ambulatory Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 135: Latin America Historic Review for Ophthalmoplegia by End-Use - Hospitals End-Use, Clinics End-Use and Ambulatory Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 136: Latin America 16-Year Perspective for Ophthalmoplegia by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Clinics End-Use and Ambulatory Clinics End-Use for the Years 2014, 2025 & 2030
  • ARGENTINA
    • TABLE 137: Argentina Recent Past, Current & Future Analysis for Ophthalmoplegia by Product Type - Ophthalmoplegia Pharmaceuticals and Ophthalmoplegia Medical Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 138: Argentina Historic Review for Ophthalmoplegia by Product Type - Ophthalmoplegia Pharmaceuticals and Ophthalmoplegia Medical Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 139: Argentina 16-Year Perspective for Ophthalmoplegia by Product Type - Percentage Breakdown of Value Sales for Ophthalmoplegia Pharmaceuticals and Ophthalmoplegia Medical Devices for the Years 2014, 2025 & 2030
    • TABLE 140: Argentina Recent Past, Current & Future Analysis for Ophthalmoplegia by End-Use - Hospitals End-Use, Clinics End-Use and Ambulatory Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 141: Argentina Historic Review for Ophthalmoplegia by End-Use - Hospitals End-Use, Clinics End-Use and Ambulatory Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 142: Argentina 16-Year Perspective for Ophthalmoplegia by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Clinics End-Use and Ambulatory Clinics End-Use for the Years 2014, 2025 & 2030
  • BRAZIL
    • TABLE 143: Brazil Recent Past, Current & Future Analysis for Ophthalmoplegia by Product Type - Ophthalmoplegia Pharmaceuticals and Ophthalmoplegia Medical Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 144: Brazil Historic Review for Ophthalmoplegia by Product Type - Ophthalmoplegia Pharmaceuticals and Ophthalmoplegia Medical Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 145: Brazil 16-Year Perspective for Ophthalmoplegia by Product Type - Percentage Breakdown of Value Sales for Ophthalmoplegia Pharmaceuticals and Ophthalmoplegia Medical Devices for the Years 2014, 2025 & 2030
    • TABLE 146: Brazil Recent Past, Current & Future Analysis for Ophthalmoplegia by End-Use - Hospitals End-Use, Clinics End-Use and Ambulatory Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 147: Brazil Historic Review for Ophthalmoplegia by End-Use - Hospitals End-Use, Clinics End-Use and Ambulatory Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 148: Brazil 16-Year Perspective for Ophthalmoplegia by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Clinics End-Use and Ambulatory Clinics End-Use for the Years 2014, 2025 & 2030
  • MEXICO
    • TABLE 149: Mexico Recent Past, Current & Future Analysis for Ophthalmoplegia by Product Type - Ophthalmoplegia Pharmaceuticals and Ophthalmoplegia Medical Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 150: Mexico Historic Review for Ophthalmoplegia by Product Type - Ophthalmoplegia Pharmaceuticals and Ophthalmoplegia Medical Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 151: Mexico 16-Year Perspective for Ophthalmoplegia by Product Type - Percentage Breakdown of Value Sales for Ophthalmoplegia Pharmaceuticals and Ophthalmoplegia Medical Devices for the Years 2014, 2025 & 2030
    • TABLE 152: Mexico Recent Past, Current & Future Analysis for Ophthalmoplegia by End-Use - Hospitals End-Use, Clinics End-Use and Ambulatory Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 153: Mexico Historic Review for Ophthalmoplegia by End-Use - Hospitals End-Use, Clinics End-Use and Ambulatory Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 154: Mexico 16-Year Perspective for Ophthalmoplegia by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Clinics End-Use and Ambulatory Clinics End-Use for the Years 2014, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 155: Rest of Latin America Recent Past, Current & Future Analysis for Ophthalmoplegia by Product Type - Ophthalmoplegia Pharmaceuticals and Ophthalmoplegia Medical Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 156: Rest of Latin America Historic Review for Ophthalmoplegia by Product Type - Ophthalmoplegia Pharmaceuticals and Ophthalmoplegia Medical Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 157: Rest of Latin America 16-Year Perspective for Ophthalmoplegia by Product Type - Percentage Breakdown of Value Sales for Ophthalmoplegia Pharmaceuticals and Ophthalmoplegia Medical Devices for the Years 2014, 2025 & 2030
    • TABLE 158: Rest of Latin America Recent Past, Current & Future Analysis for Ophthalmoplegia by End-Use - Hospitals End-Use, Clinics End-Use and Ambulatory Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 159: Rest of Latin America Historic Review for Ophthalmoplegia by End-Use - Hospitals End-Use, Clinics End-Use and Ambulatory Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 160: Rest of Latin America 16-Year Perspective for Ophthalmoplegia by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Clinics End-Use and Ambulatory Clinics End-Use for the Years 2014, 2025 & 2030
  • MIDDLE EAST
    • Ophthalmoplegia Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 161: Middle East Recent Past, Current & Future Analysis for Ophthalmoplegia by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 162: Middle East Historic Review for Ophthalmoplegia by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 163: Middle East 16-Year Perspective for Ophthalmoplegia by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2025 & 2030
    • TABLE 164: Middle East Recent Past, Current & Future Analysis for Ophthalmoplegia by Product Type - Ophthalmoplegia Pharmaceuticals and Ophthalmoplegia Medical Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 165: Middle East Historic Review for Ophthalmoplegia by Product Type - Ophthalmoplegia Pharmaceuticals and Ophthalmoplegia Medical Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 166: Middle East 16-Year Perspective for Ophthalmoplegia by Product Type - Percentage Breakdown of Value Sales for Ophthalmoplegia Pharmaceuticals and Ophthalmoplegia Medical Devices for the Years 2014, 2025 & 2030
    • TABLE 167: Middle East Recent Past, Current & Future Analysis for Ophthalmoplegia by End-Use - Hospitals End-Use, Clinics End-Use and Ambulatory Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 168: Middle East Historic Review for Ophthalmoplegia by End-Use - Hospitals End-Use, Clinics End-Use and Ambulatory Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 169: Middle East 16-Year Perspective for Ophthalmoplegia by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Clinics End-Use and Ambulatory Clinics End-Use for the Years 2014, 2025 & 2030
  • IRAN
    • TABLE 170: Iran Recent Past, Current & Future Analysis for Ophthalmoplegia by Product Type - Ophthalmoplegia Pharmaceuticals and Ophthalmoplegia Medical Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 171: Iran Historic Review for Ophthalmoplegia by Product Type - Ophthalmoplegia Pharmaceuticals and Ophthalmoplegia Medical Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 172: Iran 16-Year Perspective for Ophthalmoplegia by Product Type - Percentage Breakdown of Value Sales for Ophthalmoplegia Pharmaceuticals and Ophthalmoplegia Medical Devices for the Years 2014, 2025 & 2030
    • TABLE 173: Iran Recent Past, Current & Future Analysis for Ophthalmoplegia by End-Use - Hospitals End-Use, Clinics End-Use and Ambulatory Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 174: Iran Historic Review for Ophthalmoplegia by End-Use - Hospitals End-Use, Clinics End-Use and Ambulatory Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 175: Iran 16-Year Perspective for Ophthalmoplegia by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Clinics End-Use and Ambulatory Clinics End-Use for the Years 2014, 2025 & 2030
  • ISRAEL
    • TABLE 176: Israel Recent Past, Current & Future Analysis for Ophthalmoplegia by Product Type - Ophthalmoplegia Pharmaceuticals and Ophthalmoplegia Medical Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 177: Israel Historic Review for Ophthalmoplegia by Product Type - Ophthalmoplegia Pharmaceuticals and Ophthalmoplegia Medical Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 178: Israel 16-Year Perspective for Ophthalmoplegia by Product Type - Percentage Breakdown of Value Sales for Ophthalmoplegia Pharmaceuticals and Ophthalmoplegia Medical Devices for the Years 2014, 2025 & 2030
    • TABLE 179: Israel Recent Past, Current & Future Analysis for Ophthalmoplegia by End-Use - Hospitals End-Use, Clinics End-Use and Ambulatory Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 180: Israel Historic Review for Ophthalmoplegia by End-Use - Hospitals End-Use, Clinics End-Use and Ambulatory Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 181: Israel 16-Year Perspective for Ophthalmoplegia by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Clinics End-Use and Ambulatory Clinics End-Use for the Years 2014, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 182: Saudi Arabia Recent Past, Current & Future Analysis for Ophthalmoplegia by Product Type - Ophthalmoplegia Pharmaceuticals and Ophthalmoplegia Medical Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 183: Saudi Arabia Historic Review for Ophthalmoplegia by Product Type - Ophthalmoplegia Pharmaceuticals and Ophthalmoplegia Medical Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 184: Saudi Arabia 16-Year Perspective for Ophthalmoplegia by Product Type - Percentage Breakdown of Value Sales for Ophthalmoplegia Pharmaceuticals and Ophthalmoplegia Medical Devices for the Years 2014, 2025 & 2030
    • TABLE 185: Saudi Arabia Recent Past, Current & Future Analysis for Ophthalmoplegia by End-Use - Hospitals End-Use, Clinics End-Use and Ambulatory Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 186: Saudi Arabia Historic Review for Ophthalmoplegia by End-Use - Hospitals End-Use, Clinics End-Use and Ambulatory Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 187: Saudi Arabia 16-Year Perspective for Ophthalmoplegia by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Clinics End-Use and Ambulatory Clinics End-Use for the Years 2014, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 188: UAE Recent Past, Current & Future Analysis for Ophthalmoplegia by Product Type - Ophthalmoplegia Pharmaceuticals and Ophthalmoplegia Medical Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 189: UAE Historic Review for Ophthalmoplegia by Product Type - Ophthalmoplegia Pharmaceuticals and Ophthalmoplegia Medical Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 190: UAE 16-Year Perspective for Ophthalmoplegia by Product Type - Percentage Breakdown of Value Sales for Ophthalmoplegia Pharmaceuticals and Ophthalmoplegia Medical Devices for the Years 2014, 2025 & 2030
    • TABLE 191: UAE Recent Past, Current & Future Analysis for Ophthalmoplegia by End-Use - Hospitals End-Use, Clinics End-Use and Ambulatory Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 192: UAE Historic Review for Ophthalmoplegia by End-Use - Hospitals End-Use, Clinics End-Use and Ambulatory Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 193: UAE 16-Year Perspective for Ophthalmoplegia by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Clinics End-Use and Ambulatory Clinics End-Use for the Years 2014, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 194: Rest of Middle East Recent Past, Current & Future Analysis for Ophthalmoplegia by Product Type - Ophthalmoplegia Pharmaceuticals and Ophthalmoplegia Medical Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 195: Rest of Middle East Historic Review for Ophthalmoplegia by Product Type - Ophthalmoplegia Pharmaceuticals and Ophthalmoplegia Medical Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 196: Rest of Middle East 16-Year Perspective for Ophthalmoplegia by Product Type - Percentage Breakdown of Value Sales for Ophthalmoplegia Pharmaceuticals and Ophthalmoplegia Medical Devices for the Years 2014, 2025 & 2030
    • TABLE 197: Rest of Middle East Recent Past, Current & Future Analysis for Ophthalmoplegia by End-Use - Hospitals End-Use, Clinics End-Use and Ambulatory Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 198: Rest of Middle East Historic Review for Ophthalmoplegia by End-Use - Hospitals End-Use, Clinics End-Use and Ambulatory Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 199: Rest of Middle East 16-Year Perspective for Ophthalmoplegia by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Clinics End-Use and Ambulatory Clinics End-Use for the Years 2014, 2025 & 2030
  • AFRICA
    • Ophthalmoplegia Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 200: Africa Recent Past, Current & Future Analysis for Ophthalmoplegia by Product Type - Ophthalmoplegia Pharmaceuticals and Ophthalmoplegia Medical Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 201: Africa Historic Review for Ophthalmoplegia by Product Type - Ophthalmoplegia Pharmaceuticals and Ophthalmoplegia Medical Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 202: Africa 16-Year Perspective for Ophthalmoplegia by Product Type - Percentage Breakdown of Value Sales for Ophthalmoplegia Pharmaceuticals and Ophthalmoplegia Medical Devices for the Years 2014, 2025 & 2030
    • TABLE 203: Africa Recent Past, Current & Future Analysis for Ophthalmoplegia by End-Use - Hospitals End-Use, Clinics End-Use and Ambulatory Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 204: Africa Historic Review for Ophthalmoplegia by End-Use - Hospitals End-Use, Clinics End-Use and Ambulatory Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 205: Africa 16-Year Perspective for Ophthalmoplegia by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Clinics End-Use and Ambulatory Clinics End-Use for the Years 2014, 2025 & 2030

IV. COMPETITION

샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제